October 11, 2019 /

DPT Meeting: FDA Opening Remarks

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

DPT Meeting: FDA Opening Remarks

AGENDA

Opening Remarks

  • Janet Woodcock, MD, U.S. Food and Drug Administration
  • Billy Dunn, MD, U.S. Food and Drug Administration
2019 Duchenne Platform Trial Stakeholder Meeting,
Conferences & Meetings

Join Our Mailing List